GRAIL Inc. (GRAL)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$76.61
-1.28%
Mkt Cap $3.45B
Analyst Ratings
Buy
2
Hold
2
Sell
0
Price Target (16 analysts)
$74.43
Range $56.00 – $130.00
Implied Upside
-2.8%
Consensus $74.43 vs current $76.61
NASDAQ·Healthcare·Medical - Diagnostics & Research
$76.61
-1.28%
Mkt Cap $3.45B
Buy
2
Hold
2
Sell
0
Price Target (16 analysts)
$74.43
Range $56.00 – $130.00
-2.8%
Consensus $74.43 vs current $76.61